First, the use of a single baseline PCSK9 measurement to predict outcomes was a simplified and practical approach, though it did not allow us to assess the relationship between changes in PCSK9 levels and the risk of incident type 2 diabetes. This evidence concerns the gene PCSK9 and type 2 diabetes mellitus.